N/A N=13 Randomized Treatment

Initiation of CPAP for Newly Diagnosed OSA in Hospitalized Heart Failure Patients

Sleep Apnea, Obstructive · Heart Failure

Bottom Line

View on ClinicalTrials.gov: NCT03056443 ↗

Enrolled (actual)

Serious AEs

15.4%

Results posted

Feb 2022

Primary outcome: Primary: All-cause Hospital Readmission Within 30 Days of Hospital Discharge. — 3 readmissions

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: Continuous Positive Airway Pressure (CPAP) (Device)
Age: Adult, Older Adult · 18+ yrs
Sex: All
Sponsor: West Virginia University
Primary completion: Dec 2017

Outcome Measures

Outcome	Result	p-value
PRIMARY All-cause Hospital Readmission Within 30 Days of Hospital Discharge.	3	—

Summary

The study aimed to examine the effect of Continuous Positive Airway Pressure (CPAP) initiation for newly diagnosed obstructive sleep apnea (OSA) in hospitalized heart failure patients on reducing 30-day hospital readmission rate through a clinical trial.

Eligibility Criteria

Inclusion Criteria

Hospitalized having a documented history of heart failure
Anticipated hospitalization of more than 24 hours
Subject has obtained a score of > 15 on the Ohio Sleep Medicine Institute Preoperative questionnaire.
Subject has an apnea-hypopneas index (AHI) of > 5/h as confirmed by sleep medicine physician

Exclusion Criteria

The presence of any conditions that the investigator feels will interfere with the use of CPAP

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03056443). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.